EZH2 Histone Methyltransferase and JMJD3 Histone Demethylase Implications in Prostate Cancer

OMICS. 2017 Dec;21(12):751-753. doi: 10.1089/omi.2017.0106. Epub 2017 Nov 21.

Authors

Mouhamed Idrissou^{1

2}, Marine Daures^{1

2}, Amani Ben Jemia^{1

2}, Gaëlle Judes^{1

2}, Khaldoun Rifaï^{1

2}, Frédérique Penault-Llorca^{2

3}, Yves-Jean Bignon^{1

2}, Laurent Guy^{2

4}, Dominique Bernard-Gallon^{1

2}

Affiliations

¹ 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .
² 2 INSERM U1240 , IMOST, Clermont-Ferrand, France .
³ 3 Department of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France .
⁴ 4 Department of Urology, CHU Gabriel Montpied , Clermont-Ferrand, France .

PMID: 29161520
DOI: 10.1089/omi.2017.0106

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / enzymology*
Adenocarcinoma / genetics
Enhancer of Zeste Homolog 2 Protein / genetics
Enhancer of Zeste Homolog 2 Protein / metabolism*
Epigenomics*
Histones / genetics*
Humans
Jumonji Domain-Containing Histone Demethylases / genetics
Jumonji Domain-Containing Histone Demethylases / metabolism*
Male
Methylation
Promoter Regions, Genetic / genetics
Prostatic Neoplasms / enzymology*
Prostatic Neoplasms / genetics

Substances

Histones
Jumonji Domain-Containing Histone Demethylases
KDM6B protein, human
EZH2 protein, human
Enhancer of Zeste Homolog 2 Protein